Newsroom

The latest news and developments in our effort to change cancer care through early detection.

Take me to:

News releases

GRAIL Presents Interventional PATHFINDER Study Data at 2021 ASCO Annual Meeting and Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test

View Full Release

06/04/2021

Statement on the Passing of Dr. José Baselga, from his friends at GRAIL

View Full Release

03/21/2021

GRAIL, AccessHope Collaborate to Optimize Patient and Healthcare Provider Experience for Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test

View Full Release

03/16/2021

GRAIL Announces First Health System to Offer Galleri, Novel Multi-Cancer Early Detection Blood Test

View Full Release

03/02/2021

Multi-Cancer Early Detection Company GRAIL Now Hiring For State-Of-The-Art Laboratory Facility in Research Triangle Park

View Full Release

02/25/2021

GRAIL and Quest Diagnostics Announce Collaboration to Support Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test

View Full Release

02/23/2021

GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease

View Full Release

01/11/2021

GRAIL Confirms Q2 2021 Introduction of Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test

View Full Release

01/11/2021

New Research Suggests Multi-Cancer Early Detection Blood Test Could Reduce Late-Stage Cancer Diagnoses by More Than Half

View Full Release

12/16/2020

GRAIL and UK Government to Make Galleri Multi-Cancer Early Detection Blood Test Available to Patients

View Full Release

11/26/2020

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

View Full Release

09/21/2020

GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering

View Full Release

09/09/2020

Cleveland Clinic Joins Interventional Study Using GRAIL's Multi-Cancer Early Detection Test to Help Guide Clinical Care

View Full Release

08/06/2020

GRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II

View Full Release

06/22/2020

GRAIL Stands Against Injustice and Racism

View Full Release

06/06/2020

NC Gov. Cooper: Governor Cooper Announces Nearly 400 New Jobs in Durham as Multi-Cancer Early Detection Company Chooses New Laboratory Location

View Full Release

06/02/2020

GRAIL to Participate in BofA Securities 2020 Health Care Conference

View Full Release

05/07/2020

GRAIL Announces $390 Million Series D Financing

View Full Release

05/06/2020

Mostafa Ronaghi Joins GRAIL’s Board of Directors

View Full Release

05/04/2020

GRAIL Appoints Satnam Alag as Senior Vice President of Software Engineering

View Full Release

04/29/2020

GRAIL to Present New Data at the American Association for Cancer Research (AACR) Annual Meeting

View Full Release

04/26/2020

GRAIL Appoints Sir Harpal Kumar as President of GRAIL Europe

View Full Release

04/10/2020

GRAIL Announces Validation of its Multi-Cancer Early Detection Test Published in Annals of Oncology

View Full Release

03/30/2020

GRAIL Initiates First Interventional Study Using its Multi-Cancer Early Detection Test to Guide Clinical Care

View Full Release

02/18/2020

GRAIL Appoints Gautam Kollu as Chief Commercial Officer

View Full Release

12/16/2019

GRAIL Appoints Matthew Young as Chief Operating Officer and Chief Financial Officer

View Full Release

10/07/2019

GRAIL Announces Positive Validation Data for its Multi-Cancer Early Detection Test

View Full Release

10/07/2019

GRAIL Appoints Marissa Song as General Counsel and Corporate Secretary

View Full Release

09/30/2019

GRAIL to Present New Data in Late-Breaking Oral Presentation at the European Society for Medical Oncology (ESMO) 2019 Congress

View Full Release

09/27/2019

GRAIL Appoints Rodger Currie as Head of Government Affairs and Alliance Development

View Full Release

08/26/2019

GRAIL Announces Appointment of Hans Bishop as Chief Executive Officer and Strengthens Leadership Team and Board of Directors with New Appointments

View Full Release

06/06/2019

GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study

View Full Release

05/31/2019

GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at 2019 American Society of Clinical Oncology Annual Meeting

View Full Release

05/15/2019

GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation

View Full Release

05/13/2019

GRAIL Announces Appointment of Catherine Friedman as Chair of GRAIL Board

View Full Release

12/10/2018

GRAIL Announces Plans to Initiate SUMMIT Study to Support Development of Blood Test for Early Cancer Detection

View Full Release

12/03/2018

GRAIL to Present New Data from the Circulating Cell-free Genome Atlas (CCGA) Study at the European Society for Medical Oncology (ESMO) 2018 Congress

View Full Release

10/19/2018

GRAIL Announces Appointment of Renée Galá as Chief Financial Officer

View Full Release

10/04/2018

GRAIL Announces Appointment of Hal Barron and Hans Bishop to its Board of Directors

View Full Release

08/09/2018

GRAIL Announces Appointment of Key Executives as Company Makes Continued Progress in Development of Early Detection Products

View Full Release

07/09/2018

GRAIL Announces Data on Detection of Early-Stage Lung Cancers

View Full Release

06/02/2018

GRAIL Announces $300 Million Raised in Oversubscribed Series C Financing

View Full Release

05/21/2018

GRAIL to Present New Data from Circulating Cell-free Genome Atlas (CCGA) Study at 2018 American Society of Clinical Oncology Annual Meeting

View Full Release

05/16/2018

GRAIL Announces Data from Prototype Blood Tests for Early Cancer Detection

View Full Release

04/17/2018

GRAIL Announces Appointment of Jennifer Cook as Chief Executive Officer

View Full Release

12/14/2017

GRAIL Appoints Chairman Bill Rastetter to Chief Executive Officer

View Full Release

08/02/2017

GRAIL Announces Data From Early Research Analyzing its High-Intensity Sequencing Approach

View Full Release

06/03/2017

GRAIL Announces Board of Directors Appointments

View Full Release

05/04/2017

GRAIL Initiates the STRIVE Study to Advance Development of Blood Tests to Detect Cancer Early

View Full Release

04/20/2017

GRAIL and Cirina Combine to Create Global Company Focused on Early Detection of Cancer

View Full Release

03/31/2017

GRAIL Closes Over $900 Million Initial Investment in Series B Financing to Develop Blood Tests to Detect Cancer Early

View Full Release

03/01/2017

GRAIL Plans to Raise in Excess of $1B in Series B Funding

View Full Release

01/05/2017

GRAIL Announces Circulating Cell-free Genome Atlas (CCGA) Study as Foundation for Development of Blood Test to Detect Cancer Early

View Full Release

12/01/2016

GRAIL Hires Google Executive Jeff Huber as CEO to Lead Development for Early Cancer Detection

View Full Release

02/10/2016

Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening

View Full Release

01/10/2016

Company news

Catching cancer extremely early

Read Article

03/26/2021 | Science Magazine

This New Blood Test Can Detect 50 Types of Cancers

Read Article

03/17/2021 | Healthline

A New Early-Detection Blood Test Marks a Leap Forward in the War on Cancer

Read Article

01/21/2021 | Fast Company

AJMC, Novel Multicancer Early Detection Technology—Potential Value to Employers and the Workforce

Read Article

12/18/2020 | AJMC

A Novel Early Detection Blood Test Could Soon Change How Cancer is Found

Read Blog Post

12/18/2020

The Guardian view on a new test for cancer: grounds for optimism

Read Article

12/01/2020 | The Guardian

Taking Early Cancer Detection to the Next Level

Read Article

11/01/2020 | Scientific American

Can a blood test detect cancer in asymptomatic patients?

Read Article

10/28/2020 | CURE Magazine

The Cancer Detection Rate--a Public Health Approach to Early Detection

Read Article

10/02/2020 | The Cancer Letter

Cancer Screening Leaps Forward

Read Article

07/05/2020 | WSJ

Entering a New Era of Early Cancer Detection

Read Blog Post

05/28/2020

Grail's cancer blood test tracks down over 50 types of early-stage disease in study

Read Article

03/31/2020 | FierceBiotech

‘Simple blood test’ could give us an early warning system for cancer

Read Article

02/14/2020 | The Smithsonian

GRAIL and the quest for earlier multi-cancer detection

Read Article

02/01/2020 | Nature Outlook

Working to Transform Cancer Care Through Early Detection

Read Blog Post

11/17/2019

Striving for Earlier Cancer Detection

Fact sheets

Galleri Development Timeline

Download Fact Sheet

06/21/2021

What is the Galleri test?

Download Fact Sheet

06/04/2021

GRAIL Corporate Fact Sheet

Download Fact Sheet

10/26/2020

Multi-Cancer Early Detection Fact Sheet

Explainer Videos

It is our capability and our commitment that make us GRAIL

Media kit

Download Galleri Logo

Contact Public Relations

pr@grail.com

1525 O'Brien Drive

Menlo Park, CA 94025

833-694-2553

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.